BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16488189)

  • 1. Circulating tumor cells: the 'leukemic phase' of solid cancers.
    Mocellin S; Keilholz U; Rossi CR; Nitti D
    Trends Mol Med; 2006 Mar; 12(3):130-9. PubMed ID: 16488189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells (CTC) detection: clinical impact and future directions.
    Paterlini-Brechot P; Benali NL
    Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated and circulating tumor cells: Role in effective cancer management.
    Lin H; Balic M; Zheng S; Datar R; Cote RJ
    Crit Rev Oncol Hematol; 2011 Jan; 77(1):1-11. PubMed ID: 20570170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
    Budd GT
    Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
    Mostert B; Sleijfer S; Foekens JA; Gratama JW
    Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells and bone marrow micrometastasis.
    Alix-Panabières C; Riethdorf S; Pantel K
    Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essentials of circulating tumor cells for clinical research and practice.
    Liberko M; Kolostova K; Bobek V
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumour cell detection on its way to routine diagnostic implementation?
    Sleijfer S; Gratama JW; Sieuwerts AM; Kraan J; Martens JW; Foekens JA
    Eur J Cancer; 2007 Dec; 43(18):2645-50. PubMed ID: 17977713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
    Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
    Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New technologies for the detection of circulating tumour cells.
    Gerges N; Rak J; Jabado N
    Br Med Bull; 2010; 94():49-64. PubMed ID: 20418405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.